Comparison Chart Cara Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 11/05/2024 am IST			5-day change	1st Jan Change
0.7156 ^USD	-5.85%		-8.04%	-3.69%

22/03	Cara Therapeutics, Inc. Announces Resignation of Dr. Joana Goncalves as Chief Medical Officer, Effective April 16, 2024	CI
06/03	Canaccord Genuity Adjusts Cara Therapeutics Price Target to $10 From $11, Maintains Buy Rating	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	CARA THERAPEUTICS, INC.	Biopharmaceuticals	-5.85%	-8.04%	-3.69%	-82.76%	-96.20%	39.12M